Patent Assignment
Reel/Frame 053661/0639
Assignment of Assignor's Interest
Recorded: 2020-09-01
Pages: 11
Assignor
THE OHIO STATE UNIVERSITY
Executed: 2013-08-01
Assignee
OHIO STATE INNOVATION FOUNDATION
1524 NORTH HIGH STREET, COLUMBUS, OHIO, 43201
Covered Properties
(9)
Compounds and Compositions for Targeting Macrophages and Other Mannose-Binding C-Type Lectin Receptor High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
15/326,965 →
Publication:
US 2017/0202969
Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis
Targeting of Macrophages with a Fda Approved Drug Delivery Carrier
Application:
62/025,991 →
Compounds and Compositions for Targeting Macrophages
Application:
62/027,193 →
Compounds and Compositions for Targeting Macrophages and Methods of Treating and Diagnosis Using Same
Application:
62/027,220 →
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/027,733 →
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/106,194 →
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/187,064 →
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/187,132 →
Related Assignments
(10)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Assignment of Assignor's Interest
Sep 2, 2015
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 036477/0455 →
Release of Security Interest
Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →
Assignment of Assignor's Interest
Jun 12, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 042680/0431 →
Assignment of Assignor's Interest
Apr 22, 2020
From: BACHELDER, ERIC
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 052470/0897 →
Assignment of Assignor's Interest
Apr 22, 2020
From: BACHELDER, ERIC; JARJOUR, WAEL N.
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 052471/0097 →
Assignment of Assignor's Interest
Jul 10, 2020
From: COPE, FRED
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 053175/0528 →
Assignment of Assignor's Interest
Jul 10, 2020
From: COPE, FREDERICK O.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 053173/0784 →
Assignment of Assignor's Interest
Sep 9, 2020
From: SCHLESINGER, LARRY
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 053720/0247 →
Assignment of Assignor's Interest
Sep 21, 2020
From: SCHLESINGER, LARRY
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 053836/0183 →